Adults with obesity lost up to 22.5% of weight at 48 weeks with novel drug

Adults with obesity lost up to 22.5% of weight at 48 weeks with novel drug

January 27, 2026 2 min read Add topic to email alerts …

Continue Reading
Weight regain seems to occur within 2 years of stopping obesity drugs

Weight regain seems to occur within 2 years of stopping obesity drugs

Weight-loss drugs like Mounjaro (tirzepatide) are very effective – so long as you actually take them…

Continue Reading
Efficacy of a digital health application for weight management in people with obesity: 6-months results from a randomized controlled trial

Efficacy of a digital health application for weight management in people with obesity: 6-months results from a randomized controlled trial

Study design This study was a prospective decentralized randomized controlled trial with technology-enabled, remote recruitment, care…

Continue Reading
New Obesity Drug Helped People Lose Nearly One-Third Their Body Weight

New Obesity Drug Helped People Lose Nearly One-Third Their Body Weight

An experimental obesity drug called retatrutide that targets GLP-1 and two other hormones helped people lose…

Continue Reading
Shortage of ‘breakthrough’ weight loss drugs will slow fight against obesity, WHO warns | Obesity

Shortage of ‘breakthrough’ weight loss drugs will slow fight against obesity, WHO warns | Obesity

Weight loss drugs such as Mounjaro offer huge potential to tackle soaring obesity globally but are…

Continue Reading
WHO backs wider use of weight-loss medicines, calling obesity a chronic disease

WHO backs wider use of weight-loss medicines, calling obesity a chronic disease

The guidance focuses on GLP-1 therapies – medicines such as liraglutide, semaglutide and tirzepatide – and…

Continue Reading